# The IN.PACT SFA Clinical Study for the Treatment of Atherosclerotic Lesions in the Superficial Femoral Artery and/or Proximal Popliteal Artery Using the IN.PACT Admiral™ Drug-Eluting Balloon in a Chinese Patient Population

Study · id `cardio:ct-nct02118532` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02118532](<https://clinicaltrials.gov/study/NCT02118532>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT02118532

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 143 participants.

## Technical summary

Registry record NCT02118532. Allocation not applicable; no masking; primary purpose treatment. Start 2014-03 (registry gives no type); primary completion 2016-08 (actual). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 143 participants (enrolled count; ClinicalTrials.gov record NCT02118532, source copy `cardio:ctgov-nct02118532-2016-12-30`, retrieved 2026-10-31)
- Start date: 2014-03 (registry gives no type) (ClinicalTrials.gov record NCT02118532, source copy `cardio:ctgov-nct02118532-2016-12-30`, retrieved 2026-10-31)
- Primary completion: 2016-08 (actual) (ClinicalTrials.gov record NCT02118532, source copy `cardio:ctgov-nct02118532-2016-12-30`, retrieved 2026-10-31)
- Completion: 2016-09 (actual) (ClinicalTrials.gov record NCT02118532, source copy `cardio:ctgov-nct02118532-2016-12-30`, retrieved 2026-10-31)
- Countries: China (ClinicalTrials.gov record NCT02118532, source copy `cardio:ctgov-nct02118532-2016-12-30`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02118532-2016-12-30`, retrieved 2026-10-31)

## The registry's words

- Brief title: The IN.PACT SFA Clinical Study for the Treatment of Atherosclerotic Lesions in the Superficial Femoral Artery and/or Proximal Popliteal Artery Using the IN.PACT Admiral™ Drug-Eluting Balloon in a Chinese Patient Population
- Condition: Atherosclerosis
- Intervention (Device): IN.PACT Admiral Paclitaxel-Eluting Percutaneous Transluminal Angioplasty (PTA) Balloon Catheter
- Lead sponsor: Medtronic Endovascular
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Atherosclerosis (`cardio:atherosclerosis`)
- Registry lists this organization as the lead sponsor: Medtronic Endovascular (`cardio:org-medtronic-endovascular`)

## Provenance

Content hash: 874b536fcb39542f19be3d34c421360bb4a0f4cd49afa55f1969635effaaf086
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
